| Market Cap | ₹144Cr | 
| ROE | 13.86% | 
| P/E Ratio(TTM) | 13.32 | 
| EPS(TTM) | 9.43 | 
| P/B Ratio | 1.74 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 34.63 | 
| Book Value | 72.35 | 
| Debt to Equity | 0.84 | 
| Face Value | 10 | 
| Parent Organisation | Parnax Lab Limited | 
| Managing Director | Mr. Baiju Shah | 
| BSE Symbol | 506128 | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%)  | 61.33  | ||
| Gland Pharma | NA (0.00%)  | 42.19  | ||
| Ajanta Pharma | NA (0.00%)  | 32.58  | ||
| Eris Lifesciences | NA (0.00%)  | 52.95  |